Cancer Crosslinks 2022 will feature updates about the most recent progress in the understanding of tumor evolution. Additional topics include emerging diagnostic and treatment options for solid and hematological cancers.
Planning is underway to gather distinguished speakers from Norway and internationally. Information about the program will be updated continuously throughout Autumn 2021.
Mariam Jamal-Hanjani, Senior Clinical Lecturer and Group Leader, Cancer Metastasis Lab, CRUK Lung Cancer Centre of Excellence, UCL Cancer Institute. Honorary Consultant in Translational Lung Oncology, UCL Hospital. Visiting Scientist, The Francis Crick Institute, London, UK
David Rimm, Professor of Pathology and Medicine, Department of Pathology, Yale University School of Medicine, and Director Translational Pathology, Yale Medicine, New Haven, USA
Angela George, Clinical Director of Genomics and Consultant Medical Oncologist in Gynaecology, Royal Marsden Hospital, London, UK
Event 2022 - Topics
Tracking Cancer Evolution through the Disease Course: Impact on Diagnostics and Treatment Decisions Today and Tomorrow, Mariam Jamal-Hanjani, UCL Cancer Institute London, UK
Current and Future Methods of Predicting Response to Immunotherapy, David Rimm, Yale Medicine, New Haven, USA
Precision Therapy for Gynaecological Cancers: Molecular Subtypes & Emerging Treatment Options,Royal Marsden Hospital, London, UK
To learn more about previous Cancer Crosslinks events, visit the GALLERY.
This meeting series is organized by Oslo Cancer Cluster. Cancer Crosslinks 2022 partners are Bristol Myers Squibb & GSK.